Weight-loss drug boom raisES QUEstions about the pharmaceutical industry

publicat 2026-05-06 00:00:08 (Bursa)
The spectacular increase in demand for obesity and diabetes drugs, especially those in the GLP-1 class, is starting to raise concerns about the emergence of a possible 'bubble and #8221; in the pharmaceutical industry, according to a report by Deloitte and cited by CNBC. ...continuare.
EMAG


© Copyright 2000-2026 iStorm. Toate drepturile rezervate.